ID   UCI 107
AC   CVCL_5381
SY   UCI-107; UCI107; University of California, Irvine 107
DR   BTO; BTO_0004036
DR   CLO; CLO_0037205
DR   cancercelllines; CVCL_5381
DR   Cosmic; 1113281
DR   GEO; GSM459738
DR   Progenetix; CVCL_5381
DR   Wikidata; Q54989620
RX   PubMed=7672698;
RX   PubMed=9554442;
RX   PubMed=11314036;
RX   PubMed=12080474;
RX   PubMed=15677628;
CC   Doubling time: 24-36 hours (PubMed=7672698).
CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=7672698; DOI=10.1006/gyno.1995.1239;
RA   Gamboa-Vujicic G., Carpenter P.M., Podnos Y.D., Dorion G., Iravani L.,
RA   Bolton D., Mascarello J.T., Manetta A.;
RT   "Characterization and development of UCI 107, a primary human ovarian
RT   carcinoma cell line.";
RL   Gynecol. Oncol. 58:336-343(1995).
//
RX   PubMed=9554442; DOI=10.1093/jnci/90.8.597;
RA   Sabichi A.L., Hendricks D.T., Bober M.A., Birrer M.J.;
RT   "Retinoic acid receptor beta expression and growth inhibition of
RT   gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl)
RT   retinamide.";
RL   J. Natl. Cancer Inst. 90:597-605(1998).
//
RX   PubMed=11314036; DOI=10.1038/sj.onc.1204211;
RA   Forgacs E., Wren J.D., Kamibayashi C., Kondo M., Xu X.L.,
RA   Markowitz S.D., Tomlinson G.E., Muller C.Y., Gazdar A.F., Garner H.R.,
RA   Minna J.D.;
RT   "Searching for microsatellite mutations in coding regions in lung,
RT   breast, ovarian and colorectal cancers.";
RL   Oncogene 20:1005-1009(2001).
//
RX   PubMed=12080474; DOI=10.1038/sj.onc.1205542;
RA   Manzano R.G., Montuenga L.M., Dayton M.A., Dent P., Kinoshita I.,
RA   Vicent S., Gardner G.J., Nguyen P., Choi Y.-H., Trepel J.B.,
RA   Auersperg N., Birrer M.J.;
RT   "CL100 expression is down-regulated in advanced epithelial ovarian
RT   cancer and its re-expression decreases its malignant potential.";
RL   Oncogene 21:4435-4447(2002).
//
RX   PubMed=15677628; DOI=10.1093/carcin/bgi032;
RA   Gorringe K.L., Chin S.-F., Pharoah P.D.P., Staines J.M., Oliveira C.,
RA   Edwards P.A.W., Caldas C.;
RT   "Evidence that both genetic instability and selection contribute to
RT   the accumulation of chromosome alterations in cancer.";
RL   Carcinogenesis 26:923-930(2005).
//